MMHC News--Medically Minded Initial Sales Test Marketing of Recently Acquired Inventory Estimates Retail Value in Excess of $150,000
May 26, 2016
OTC Disclosure & News Service
West Palm Beach, FL -
Medically Minded Initial Sales Test Marketing of Recently Acquired Inventory Estimates Retail Value in Excess of $150,000
WEST PALM BEACH, FLORIDA--(May 26, 2016) - Medically Minded, Inc. (OTC PINK: MMHC), announced today that it has completed various sales test marketing of the products recently acquired and delivered from Health Synergy, Inc. The test marketing involved the pricing of the products under tiered pricing structures to determine the most favorable price point for each item. The Company, based on these test efforts, has experienced daily revenues and established what it believes to be the optimal pricing points to generate the most sales.
The Company’s initial inventory of products include CBD Vape Oil in 3 Flavors (Strawberry Kiwi, Rainbow Cream and Menthol) of 50mg or 150mg, CBD Honey Stix 3 -Pack, Pharma Grade CBD Energy Powder, CBD Infused Shampoo, CBD Infused Conditioner and CBD Infused Body Lotion. The Company has placed an estimated retail value in excess of $150,000 on this inventory based on the number of units of each product on hand along with the recently established pricing structures. The inventory does not include the Company’s recently announced launch of a Medically Minded brand of 0.5 ounce and 1-ounce Hemp Oil Tinctures, which the Company expects to take initial delivery of over the next couple of weeks.
James Grady, CEO of Medically Minded, stated, “The true value I see in our recently tested pricing structures is that we have acquired over 100 customers in a matter of weeks and established that we have a significant enough value of inventory to fund the Company’s continued product acquisition and marketing in the short term.” Grady continued, “By achieving our estimated value of the current inventory we will be generating internal funding that is not dependent on outside financing”.
Medically Minded’s current offering and pricing of inventoried product available at www.medmindedlabs.com is:
-Vape Oil 10ml 50mg (Strawberry Kiwi, Rainbow Cream and Menthol) $9.99
-Vape Oil 10ml 150mg (Strawberry Kiwi, Rainbow Cream and Menthol) $19.99
-Honey Stix (20ct Box of 3 packs) (60 Stix) 5mg CBD each Stick (300mg Total) $39.99
-Honey Stix Individual 3 Pack 5mg CBD per Stick (15mg Total) $3.95
-CBD Infused Shampoo (8 ounce) $5.99
-CBD Infused Conditioner (8 ounce) $5.99
-CBD Infused Body Lotion (8 ounce) $10.99
-Various Combo Packs and Bulk Purchase Discounts also available.
Additionally, in honor of Memorial Day, the Company is offering a discount of 25% OFF all purchases at the Company’s website (www.medmindedlabs.com) by using the code THANKYOU at checkout.
About Cannabidiol (“CBD”) Oil
CBD Rich Hemp Oil is an oil extracted from Industrial Hemp plants (stalks and seeds) with a High Grade of Cannabidiol (CBD). The plants used are specifically and uniquely bred to comprise high concentrations of the naturally occurring Cannabinoid Cannabidiol (CBD). Cannabidiol oil that comes from industrial hemp plants, such as will be the case with our products, are considered by the FDA to be a dietary supplement (not a medication) since they are made from industrial hemp plants.
If you live in the US, this means you don’t need a prescription and can legally purchase and consume Cannabidiol in any state. Cannabidiol from industrial hemp also has the added benefit of having virtually no THC. This is why it’s not possible to get “high” with these products. There simply isn’t enough THC.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program.
SAFE HARBOR AND INFORMATIONAL STATEMENT
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of fact, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may", "would", "will", "expect", "estimate", "anticipate", "believe", "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. The Company is not eligible to rely on the safe harbor provided by Section 21E(c) of the Exchange Act because it is not subject to filing periodic reports under Sections 13 or 15(d) of the Exchange Act.
Contact:
James Grady, CEO
(954) 210-8063
Info@medmindedlabs.com
AI
